Projects funded by the NCN
Anticancer activity of novel derivatives of 9,10-Anthraquinone Dithiocarbamates
2021/41/N/NZ7/03707
Keywords:
9,10-Anthraquinone telomerase telomeres lung cancer
Descriptors:
- NZ7_014:
- NZ5_007:
Panel:
NZ7 - Diagnostic tools, therapies and public health: public health, epidemiology, environmental health risks and occupational medicine, medical ethics, drug discovery and therapies, pharmacology
Host institution :
Politechnika Gdańska
woj. pomorskie
Principal investigator (from the host institution):
Number of co-investigators in the project: 2
Call: PRELUDIUM 20 - announced on 2021-03-15
Amount awarded: 209 947 PLN
Project start date (Y-m-d): 2022-01-10
Project end date (Y-m-d): 2025-01-09
Project duration:: 36 months (the same as in the proposal)
Project status: Project completed
Project description
Download the project description in a pdf file
Note - project descriptions were prepared by the authors of the applications themselves and placed in the system in an unchanged form.
Information in the final report
- Publication in academic press/journals (2)
- Teloxantron inhibits the processivity of telomerase with preferential DNA damage on telomeresAuthors:Natalia Maciejewska, Mateusz Olszewski, Jakub Jurasz, Maciej Baginski, Maryna Stasevych, Viktor Zvarych, Marco Folini , Nadia ZaffaroniAcademic press:Cell death & disease (rok: 2022, tom: 13, strony: 1005), Wydawca: NatureStatus:PublishedDOI:10.1038/s41419-022-05443-y - link to the publication
- Teloxantron inhibits the processivity of telomerase with preferential DNA damage on telomeresAuthors:Natalia Maciejewska, Mateusz Olszewski, Jakub Jurasz, Maciej Baginski, Maryna Stasevych, Viktor Zvarych, Marco Folini , Nadia ZaffaroniAcademic press:Cell death & disease (rok: 2022, tom: 13, strony: 1005), Wydawca: NatureStatus:PublishedDOI:10.1038/s41419-022-05443-y - link to the publication